HOUSE BILL 970
J5, J4 5lr2851
CF SB 646
By: Delegates Woods, Alston, Bagnall, Bhandari, Chisholm, Davis, Fisher, Ghrist,
Guzzone, Harris, Harrison, Kaufman, Kerr, J. Long, Lopez, Martinez,
McCaskill, M. Morgan, Patterson, Roberts, Rosenberg, Schmidt, Simmons,
Szeliga, Taveras, Taylor, Terrasa, and Wilkins Wilkins, Cullison, Hill,
Hutchinson, S. Johnson, Kaiser, Kipke, Pena–Melnyk, Reilly, Ross,
White Holland, and Woorman
Introduced and read first time: January 31, 2025
Assigned to: Health and Government Operations
Committee Report: Favorable with amendments
House action: Adopted
Read second time: February 27, 2025
CHAPTER ______
1 AN ACT concerning
2 Health Insurance – Insulin – Prohibition on Step Therapy or Fail–First
3 Protocols
4 FOR the purpose of prohibiting certain insurers, nonprofit health service plans, and health
5 maintenance organizations from imposing a step therapy or fail–first protocol on
6 insulin or certain other similar medications used to treat an insured’s or enrollee’s
7 diabetes; and generally relating to use of step therapy and fail–first protocols.
8 BY repealing and reenacting, without amendments,
9 Article – Insurance
10 Section 15–142(a)(1) and (4) and (b)
11 Annotated Code of Maryland
12 (2017 Replacement Volume and 2024 Supplement)
13 BY repealing and reenacting, with amendments,
14 Article – Insurance
15 Section 15–142(e)
16 Annotated Code of Maryland
17 (2017 Replacement Volume and 2024 Supplement)
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from existing law.
Underlining indicates amendments to bill.
Strike out indicates matter stricken from the bill by amendment or deleted from the law by
amendment. *hb0970*

2 HOUSE BILL 970
1 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
2 That the Laws of Maryland read as follows:
3 Article – Insurance
4 15–142.
5 (a) (1) In this section the following words have the meanings indicated.
6 (4) (i) “Step therapy or fail–first protocol” means a protocol established
7 by an insurer, a nonprofit health service plan, or a health maintenance organization that
8 requires a prescription drug or sequence of prescription drugs to be used by an insured or
9 an enrollee before a prescription drug ordered by a prescriber for the insured or the enrollee
10 is covered.
11 (ii) “Step therapy or fail–first protocol” includes a protocol that
12 meets the definition under subparagraph (i) of this paragraph regardless of the name, label,
13 or terminology used by the insurer, nonprofit health service plan, or health maintenance
14 organization to identify the protocol.
15 (b) (1) This section applies to:
16 (i) insurers and nonprofit health service plans that provide hospital,
17 medical, or surgical benefits to individuals or groups on an expense–incurred basis under
18 health insurance policies or contracts that are issued or delivered in the State; and
19 (ii) health maintenance organizations that provide hospital,
20 medical, or surgical benefits to individuals or groups under contracts that are issued or
21 delivered in the State.
22 (2) An insurer, a nonprofit health service plan, or a health maintenance
23 organization that provides coverage for prescription drugs through a pharmacy benefits
24 manager is subject to the requirements of this section.
25 (e) An entity subject to this section may not impose a step therapy or fail–first
26 protocol on an insured or an enrollee for a prescription drug approved by the U.S. Food and
27 Drug Administration if:
28 (1) (I) the prescription drug is used to treat the insured’s or enrollee’s
29 stage four advanced metastatic cancer; and
30 [(2)] (II) use of the prescription drug is:
31 [(i)] 1. consistent with the U.S. Food and Drug
32 Administration–approved indication or the National Comprehensive Cancer Network
33 Drugs & Biologics Compendium indication for the treatment of stage four advanced
34 metastatic cancer; and

HOUSE BILL 970 3
1 [(ii)] 2. supported by peer–reviewed medical literature; OR
2 (2) THE PRESCRIPTION DRUG IS:
3 (I) INSULIN USED TO TREAT THE INSURED’S OR ENROLLEE’S
4 TYPE 1, TYPE 2, OR GESTATIONAL DIABETES; AND
5 (II) 1. INSULIN; OR
6 2. AN INSULIN ANALOG OR OTHER PRESCRIPTION DRUG
7 THAT PERFORMS A SIMILAR FUNCTION TO INSULIN, REGARDLESS OF THE
8 ACTIVATION PERIOD, WHETHER THE SOLUTION IS MIXED BEFORE OR AFTER
9 DISPENSING, OR WHETHER THE DRUG IS ADMINISTERED BY INJECTION OR
10 INHALATION.
11 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all
12 policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or
13 after January 1, 2026.
14 SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect
15 January 1, 2026.
Approved:
________________________________________________________________________________
Governor.
________________________________________________________________________________
Speaker of the House of Delegates.
________________________________________________________________________________
President of the Senate.

[DELETED: :CA      5   C H H K K J L M T T T a W W C H S K K P R R A H P F m i d B  A S  A  ( B  A S  A  (]
[DELETED:  H   S T A 1  ( ( I   ( ( “ b r a i    ( “ t o f p i a p t m o o  ( ( T    ( i m h    ( h m o t p h m d   ( A o m  ( A p D   (  t s   () u] (    () c w t U F a D] 1 A i o t N C C N D & B C i f t t o s f a m]
[DELETED: H 3    () se] 2.    S    ) ’INU IDSES    S ,2,     ) 1 IIN       P A S F T IN R O T  PD W T S I M B O A G O W T D I A B I O  .  S p a  S A B I F E T t A s t e J          G               ]